These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

308 related items for PubMed ID: 14579092

  • 1. Radioiodinated SB 207710 as a radioligand in vivo: imaging of brain 5-HT4 receptors with SPET.
    Pike VW, Halldin C, Nobuhara K, Hiltunen J, Mulligan RS, Swahn CG, Karlsson P, Olsson H, Hume SP, Hirani E, Whalley J, Pilowsky LS, Larsson S, Schnell PO, Ell PJ, Farde L.
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1520-8. PubMed ID: 14579092
    [Abstract] [Full Text] [Related]

  • 2. [carbonyl-11C]Desmethyl-WAY-100635 (DWAY) is a potent and selective radioligand for central 5-HT1A receptors in vitro and in vivo.
    Pike VW, Halldin C, McCarron JA, Lundkvist C, Hirani E, Olsson H, Hume SP, Karlsson P, Osman S, Swahn CG, Hall H, Wikström H, Mensonidas M, Poole KG, Farde L.
    Eur J Nucl Med; 1998 Apr; 25(4):338-46. PubMed ID: 9553162
    [Abstract] [Full Text] [Related]

  • 3. N,N-dimethyl-2-(2-amino-4-(18)F-fluorophenylthio)-benzylamine (4-(18)F-ADAM): an improved PET radioligand for serotonin transporters.
    Shiue GG, Choi SR, Fang P, Hou C, Acton PD, Cardi C, Saffer JR, Greenberg JH, Karp JS, Kung HF, Shiue CY.
    J Nucl Med; 2003 Dec; 44(12):1890-7. PubMed ID: 14660713
    [Abstract] [Full Text] [Related]

  • 4. Synthesis and initial evaluation of [11C](R)-RWAY in monkey-a new, simply labeled antagonist radioligand for imaging brain 5-HT1A receptors with PET.
    McCarron JA, Zoghbi SS, Shetty HU, Vermeulen ES, Wikström HV, Ichise M, Yasuno F, Halldin C, Innis RB, Pike VW.
    Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1670-82. PubMed ID: 17579853
    [Abstract] [Full Text] [Related]

  • 5. New halogenated [11C]WAY analogues, [11C]6FPWAY and [11C]6BPWAY--radiosynthesis and assessment as radioligands for the study of brain 5-HT1A receptors in living monkey.
    Sandell J, Halldin C, Pike VW, Chou YH, Varnäs K, Hall H, Marchais S, Nowicki B, Wikström HV, Swahn CG, Farde L.
    Nucl Med Biol; 2001 Feb; 28(2):177-85. PubMed ID: 11295428
    [Abstract] [Full Text] [Related]

  • 6. Distribution of 5-HT4 receptors in the postmortem human brain--an autoradiographic study using [125I]SB 207710.
    Varnäs K, Halldin C, Pike VW, Hall H.
    Eur Neuropsychopharmacol; 2003 Aug; 13(4):228-34. PubMed ID: 12888181
    [Abstract] [Full Text] [Related]

  • 7. PET imaging of brain 5-HT1A receptors in rat in vivo with 18F-FCWAY and improvement by successful inhibition of radioligand defluorination with miconazole.
    Tipre DN, Zoghbi SS, Liow JS, Green MV, Seidel J, Ichise M, Innis RB, Pike VW.
    J Nucl Med; 2006 Feb; 47(2):345-53. PubMed ID: 16455642
    [Abstract] [Full Text] [Related]

  • 8. Synthesis and characterization of iodine-123 labeled 2beta-carbomethoxy-3beta-(4'-((Z)-2-iodoethenyl)phenyl)nortropane. A ligand for in vivo imaging of serotonin transporters by single-photon-emission tomography.
    Goodman MM, Chen P, Plisson C, Martarello L, Galt J, Votaw JR, Kilts CD, Malveaux G, Camp VM, Shi B, Ely TD, Howell L, McConathy J, Nemeroff CB.
    J Med Chem; 2003 Mar 13; 46(6):925-35. PubMed ID: 12620070
    [Abstract] [Full Text] [Related]

  • 9. Synthesis, structure-affinity relationships, and radiolabeling of selective high-affinity 5-HT4 receptor ligands as prospective imaging probes for positron emission tomography.
    Xu R, Hong J, Morse CL, Pike VW.
    J Med Chem; 2010 Oct 14; 53(19):7035-47. PubMed ID: 20812727
    [Abstract] [Full Text] [Related]

  • 10. Characterization of [(11)C]Cimbi-36 as an agonist PET radioligand for the 5-HT(2A) and 5-HT(2C) receptors in the nonhuman primate brain.
    Finnema SJ, Stepanov V, Ettrup A, Nakao R, Amini N, Svedberg M, Lehmann C, Hansen M, Knudsen GM, Halldin C.
    Neuroimage; 2014 Jan 01; 84():342-53. PubMed ID: 23994452
    [Abstract] [Full Text] [Related]

  • 11. Synthesis and structure-affinity relationships of selective high-affinity 5-HT(4) receptor antagonists: application to the design of new potential single photon emission computed tomography tracers.
    Dubost E, Dumas N, Fossey C, Magnelli R, Butt-Gueulle S, Ballandonne C, Caignard DH, Dulin F, Sopkova de-Oliveira Santos J, Millet P, Charnay Y, Rault S, Cailly T, Fabis F.
    J Med Chem; 2012 Nov 26; 55(22):9693-707. PubMed ID: 23102207
    [Abstract] [Full Text] [Related]

  • 12. Single-photon emission tomography imaging of serotonin transporters in the non-human primate brain with the selective radioligand [(123)I]IDAM.
    Acton PD, Kung MP, Mu M, Plössl K, Hou C, Siciliano M, Oya S, Kung HF.
    Eur J Nucl Med; 1999 Aug 26; 26(8):854-61. PubMed ID: 10436198
    [Abstract] [Full Text] [Related]

  • 13. Characterization of the SPECT 5-HT2A receptor ligand 123I-R91150 in healthy volunteers: part 2--ketanserin displacement.
    Catafau AM, Danus M, Bullich S, Nucci G, Llop J, Abanades S, Cunningham VJ, Eersels JL, Pavia J, Farre M.
    J Nucl Med; 2006 Jun 26; 47(6):929-37. PubMed ID: 16741301
    [Abstract] [Full Text] [Related]

  • 14. Biodistribution and displacement studies of the selective 5-HT2A receptor antagonist 123I-5-I-R91150 in the normal dog.
    Peremans K, Audenaert K, Jacobs F, Dumont F, De Vos F, Van De Wiele C, Vandecapelle M, Van Bree H, Verschooten F, Slegers G, Mertens J, Dierckx R.
    Nucl Med Commun; 2002 Oct 26; 23(10):1019-27. PubMed ID: 12352602
    [Abstract] [Full Text] [Related]

  • 15. Iodine-123 labelled Z-(R,R)-IQNP: a potential radioligand for visualization of M(1 )and M(2) muscarinic acetylcholine receptors in Alzheimer's disease.
    Bergström KA, Halldin C, Savonen A, Okubo Y, Hiltunen J, Nobuhara K, Swahn CG, Karlsson P, McPherson D, Knapp FF, Larsson S, Schnell PO, Farde L.
    Eur J Nucl Med; 1999 Nov 26; 26(11):1482-5. PubMed ID: 10552091
    [Abstract] [Full Text] [Related]

  • 16. Investigation of the metabolites of (S,S)-[(11)C]MeNER in humans, monkeys and rats.
    Schou M, Zoghbi SS, Shetty HU, Shchukin E, Liow JS, Hong J, Andrée BA, Gulyás B, Farde L, Innis RB, Pike VW, Halldin C.
    Mol Imaging Biol; 2009 Nov 26; 11(1):23-30. PubMed ID: 18800204
    [Abstract] [Full Text] [Related]

  • 17. Synthesis and characterization of EADAM: a selective radioligand for mapping the brain serotonin transporters by positron emission tomography.
    Jarkas N, McConathy J, Votaw JR, Voll RJ, Malveaux E, Camp VM, Williams L, Goodman RR, Kilts CD, Goodman MM.
    Nucl Med Biol; 2005 Jan 26; 32(1):75-86. PubMed ID: 15691664
    [Abstract] [Full Text] [Related]

  • 18. Characterisation of the appearance of radioactive metabolites in monkey and human plasma from the 5-HT1A receptor radioligand, [carbonyl-11C]WAY-100635--explanation of high signal contrast in PET and an aid to biomathematical modelling.
    Osman S, Lundkvist C, Pike VW, Halldin C, McCarron JA, Swahn CG, Farde L, Ginovart N, Luthra SK, Gunn RN, Bench CJ, Sargent PA, Grasby PM.
    Nucl Med Biol; 1998 Apr 26; 25(3):215-23. PubMed ID: 9620626
    [Abstract] [Full Text] [Related]

  • 19. Synthesis of 11C-labelled (R)-OHDMI and CFMME and their evaluation as candidate radioligands for imaging central norepinephrine transporters with PET.
    Schou M, Pike VW, Sóvágó J, Gulyás B, Gallagher PT, Dobson DR, Walter MW, Rudyk H, Farde L, Halldin C.
    Bioorg Med Chem; 2007 Jan 15; 15(2):616-25. PubMed ID: 17123820
    [Abstract] [Full Text] [Related]

  • 20. Initial evaluation of 123I-5-I-R91150, a selective 5-HT2A ligand for single-photon emission tomography, in healthy human subjects.
    Busatto GF, Pilowsky LS, Costa DC, Mertens J, Terriere D, Ell PJ, Mulligan R, Travis MJ, Leysen JE, Lui D, Gacinovic S, Waddington W, Lingford-Hughes A, Kerwin RW.
    Eur J Nucl Med; 1997 Feb 15; 24(2):119-24. PubMed ID: 9021107
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.